Your browser doesn't support javascript.
loading
Bendamustine in combination with ifosfamide, etoposide, and vinorelbine (VIBE) is an effective salvage regimen for heavily pre-treated patients with relapsed or refractory Hodgkin lymphoma: a single-center experience.
Prakash, Gaurav; Jain, Arihant; Sahu, Kamalkant; Bal, Amanjit; Singh, Charanpreet; Basher, Rajender; Singh, Harmandeep; Mishra, Kundan; Jandial, Aditya; Lad, Deepesh; Khadwal, Alka; Srinivasan, Radhika; Das, Ashim; Varma, Neelam; Varma, Subhash; Malhotra, Pankaj.
Afiliação
  • Prakash G; Clinical Hematology and BMT Division, Department of Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Jain A; Clinical Hematology and BMT Division, Department of Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Sahu K; Clinical Hematology and BMT Division, Department of Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Bal A; Department of Nuclear Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Singh C; Clinical Hematology and BMT Division, Department of Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Basher R; Department of Histopathology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Singh H; Department of Histopathology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Mishra K; Clinical Hematology and BMT Division, Department of Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Jandial A; Clinical Hematology and BMT Division, Department of Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Lad D; Clinical Hematology and BMT Division, Department of Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Khadwal A; Clinical Hematology and BMT Division, Department of Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Srinivasan R; Department of Cytopathology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Das A; Department of Nuclear Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Varma N; Department of Hematology, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Varma S; Clinical Hematology and BMT Division, Department of Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
  • Malhotra P; Clinical Hematology and BMT Division, Department of Internal Medicine, Postgraduate Institute of Medical Education and Research, Chandigarh, India.
Blood Res ; 56(3): 134-140, 2021 Sep 30.
Article em En | MEDLINE | ID: mdl-34400589
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Blood Res Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Índia
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: Blood Res Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Índia